Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBITDA Margin (2016)

Historic EBITDA Margin for Tenax Therapeutics (TENX) over the last 5 years, with Q2 2015 value amounting to 242161.79%.

  • Tenax Therapeutics' EBITDA Margin changed N/A to 242161.79% in Q2 2015 from the same period last year, while for Dec 2015 it was 3500128.74%, marking a year-over-year change of. This contributed to the annual value of 84756.52% for FY2024, which is 1168843300.0% up from last year.
  • According to the latest figures from Q2 2015, Tenax Therapeutics' EBITDA Margin is 242161.79%.
  • Tenax Therapeutics' EBITDA Margin's 5-year high stood at 14490.35% during Q2 2012, with a 5-year trough of 242161.79% in Q2 2015.
  • Over the past 4 years, Tenax Therapeutics' median EBITDA Margin value was 715.64% (recorded in 2013), while the average stood at 20932.01%.
  • In the last 5 years, Tenax Therapeutics' EBITDA Margin skyrocketed by 2000000000bps in 2011 and then tumbled by -189352200bps in 2013.
  • Over the past 4 years, Tenax Therapeutics' EBITDA Margin (Quarter) stood at 2158.73% in 2011, then surged by 94bps to 132.62% in 2012, then plummeted by -3251bps to 4444.87% in 2013, then crashed by -5348bps to 242161.79% in 2015.
  • Its EBITDA Margin was 242161.79% in Q2 2015, compared to 4444.87% in Q2 2013 and 715.64% in Q1 2013.